XCHC President & CEO, Robert Kane, Issues Cannabinoid Financial Industry Insight And Illustrates Possible Economic Impact To US Economy At Executive Breakfast
DALLAS, Feb. 28, 2013 /PRNewswire/ -- X-Change Corp. (NASDAQ OTC: XCHC), a U.S. company specializing in cannabis and hemp based extracts. The Company is focused on introducing consumer product lines that target medical cannabinoids, cosmeceutical, nutraceutical, and social usage solutions through multiple Phytiva Brand product lines, products, and services. Earlier this week, Robert Kane addressed business executives, business owners, investors, and other entrepreneurs, at an Executive Breakfast in Denver, hosted by Cloverleaf Consulting.
"My mission in my position in the Company and the industry in general is to establish the Cannabinoid Market as a viable investment alternative to all investors. These illustrations are vital for the progression of this necessary and valuable industry to establish itself. And development of this industry will result in quantifiable profits and taxes that support community programs, such as schools and civil services that are so desperately needed at this time. I'd like to thank, Chloe Villano, President of Cloverleaf, for organizing an event at which we could share this important financial data to start a legitimate, serious financial conversation with the world," stated Mr. Kane, President and CEO of X-Change Corporation.
Mr. Kane shared and updated the Company's Phytiva Brand progress with regard to the upcoming product release of the European Phytiva product line. New treatment products have been internally approved for additional commercials. These will be among the first commercials for cannabinoid-based products to air. This is in addition to progress made with the Maliseet in regards to the new facility in New Brunswick, Canada.
Mr. Kane's presentation focused on how to look at the potential billion-dollar cannabinoid industry through the eyes of the investor and the financial due process of the fundamental establishment of the legal cannabinoid industry. The due process contains progression in the areas of economics, politics, cultural, and social issues.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts